ChiCTR2600116308 版本V1.0 版本创建时间2026/01/08 09:38:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600116308 

最近更新日期:

Date of Last Refreshed on:

2026-01-08 09:38:48 

注册时间:

Date of Registration:

2026-01-08 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

IVC-CI预测全麻老年患者术后低血压的临床研究

Public title:

Clinical study on IVC-CI prediction of postoperative hypotension in elderly patients under general anesthesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

IVC-CI预测全麻老年患者术后低血压的临床研究

Scientific title:

Clinical study on IVC-CI prediction of postoperative hypotension in elderly patients under general anesthesia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

苗娜娜 

研究负责人:

张二飞 

Applicant:

Miao Nana 

Study leader:

Zhang Erfei  

申请注册联系人电话:

Applicant telephone:

+86 131 5402 5990

研究负责人电话:

Study leader's
telephone:

+86 138 9117 0975

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

3197987203@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhangerfei09@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国陕西省延安市宝塔区北大街43号

研究负责人通讯地址:

中国陕西省延安市宝塔区北大街43号

Applicant address:

43 North Street, Baota District, Yan'an, Shaanxi, China

Study leader's address:

43 North Street, Baota District, Yan'an, Shaanxi, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

延安大学附属医院

Applicant's institution:

Affiliated Hospital of Yan'an University

研究负责人所在单位:

延安大学附属医院

Affiliation of the Leader:

Affiliated Hospital of Yan'an University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

IIT-202502004-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

延安大学附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Yan‘an University Affiliated Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-03-10 00:00:00

伦理委员会联系人:

王莉

Contact Name of the ethic committee:

Wang Li

伦理委员会联系地址:

中国陕西省延安市宝塔区北大街43号

Contact Address of the ethic committee:

43 North Street, Baota District,Yan'an , Shaanxi,China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 189 9219 1702

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

延安大学附属医院

Primary sponsor:

Affiliated Hospital of Yan'an University

研究实施负责(组长)单位地址:

中国陕西省延安市宝塔区北大街43号

Primary sponsor's address:

43 North Street, Baota District,Yan'an , Shaanxi,China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

延安

Country:

China

Province:

Shaanxi

City:

Yan'an

单位(医院):

延安大学附属医院

具体地址:

中国陕西省延安市宝塔区北大街43号

Institution
hospital:

Affiliated Hospital of Yan'an University

Address:

43 North Street, Baota District,Yan'an , Shaanxi,China

经费或物资来源:

自筹

Source(s) of funding:

Self-fund

研究疾病:

全麻术后低血压  

Target disease:

Hypotension after general anesthesia

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

主要目的是评估下腔静脉塌陷指数对全麻老年患者术后低血压发生的预测准确性;次要目的包括分析不同手术类型、基础疾病状态下 IVC-CI 预测效能的差异 。  

Objectives of Study:

The primary objective is to evaluate the predictive effect of inferior vena cava collapse index on the occurrence of postoperative hypotension in older patients under general anesthesia accuracy ; Secondary objectives include analyzing the predictive performance of IVC-CI in different surgical types and underlying disease states Difference.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄>=65 岁,拟行择期全麻手术,手术时间预计超过 1 小时; 2.美国麻醉医师协会(ASA)分级 Ⅰ - Ⅲ 级; 3.患者或其家属签署知情同意书。

Inclusion criteria

1. Age >=65 years old, it is proposed to perform elective total anesthesia surgery, and the operation time is expected to exceed 1 hour; 2. American Association of Anesthesiologists (ASA) Grade I-III; 3.The patient or his/her family sign the informed consent form.

排除标准:

1.存在严重心脏瓣膜疾病、心肌病影响心脏血流动力学;2.有下腔静脉畸形、 血栓或局部病变, 干扰超声影像观察; 3.肝肾功能衰竭终末期,预期寿命短;4.无法配合完成超声检查及相关监测流程。

Exclusion criteria:

1. There is a serious heart valve disease and cardiomyopathy affecting cardiac hemodynamics; 2. There is Inferior vena cava malformation, thrombosis or local lesions interfere with ultrasound imaging observation; 3. The terminal stage of liver and kidney failure, Short life expectancy; 4. Unable to cooperate with the completion of ultrasound examination and related monitoring processes.

研究实施时间:

Study execute time:

From 2025-02-01 00:00:00 To 2026-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-03-11 00:00:00 To 2026-02-28 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

80

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

延安大学附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Yan'an University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

IVC-CI 对术后 24h 内低血压预测的 ROC 曲线下面积,敏感度和特异度的水平

指标类型:

主要指标

Outcome:

The area under the ROC curve, sensitivity, and specificity of IVC-CI for predicting hypotension within 24 hours postoperatively.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前:ASA分级、白细胞计数、血小板计数、血红蛋白、白蛋白、肌酐清除率

指标类型:

次要指标

Outcome:

Preoperative: ASA classification, white blood cell count, platelet count, hemoglobin, albumin, creatinine clearance

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中:手术入路、手术部位、手术时间、术中晶体及胶体输注量、术中出血及输血量、术中尿量、术中丙泊酚,瑞芬太尼使用量

指标类型:

次要指标

Outcome:

Intraoperative: surgical approach, surgical site, operative time, intraoperative crystalloid and colloid infusion volume, intraoperative blood loss and transfusion volume, intraoperative urine output, intraoperative propofol and remifentanil usage

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后:术后 24 h 内低血压发生率、是否应用阿片类药物进行镇痛、阿片 类药物使用量、术后 24h 晶体及胶体输注量、输血量、引流量、尿量、术后恢复 饮食时间、术后新发并发症评估:(术后肺水肿、肺部感染、胃肠道反应、伤口 延迟愈合、急性肾损伤、心脑血管事件(包括心力衰竭、脑梗死、脑出血、下肢 静脉血栓形成等)、住院时长、术后住院时长、住院费用等

指标类型:

次要指标

Outcome:

Postoperative: incidence of hypotension within 24 hours, use of opioid analgesics, total opioid dosage, intra-24h crystalloid and colloid infusion volume, blood transfusion volume, drainage volume, urine output, time to resumption of oral intake, assessment of new postoperative complications: (postoperative pulmonary edema, pulmonary infection, gastrointestinal reactions, delayed wound healing, acute kidney injury, cardiovascular and cerebrovascular events [including heart failure, cerebral infa

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age NA years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成6个月后上传原始数据至临床试验公共管理平台http://www.medresman.org.cn/ The way of sharing IPD:

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Uploading the original data to clinical trials of public management platform after test completed 6 months http://www.medresman.org.cn/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1.伦理需要的CRF表 2.电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. CRF table for ethical needs 2. Electronic acquisition and management system

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-01-08 09:38:48